BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 31157418)

  • 1. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome.
    Zamani M; Alizadeh-Tabari S; Zamani V
    Aliment Pharmacol Ther; 2019 Jul; 50(2):132-143. PubMed ID: 31157418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study.
    Koloski NA; Jones M; Talley NJ
    Aliment Pharmacol Ther; 2016 Sep; 44(6):592-600. PubMed ID: 27444264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies.
    Geng Q; Zhang QE; Wang F; Zheng W; Ng CH; Ungvari GS; Wang G; Xiang YT
    J Affect Disord; 2018 Sep; 237():37-46. PubMed ID: 29758449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.
    Klem F; Wadhwa A; Prokop LJ; Sundt WJ; Farrugia G; Camilleri M; Singh S; Grover M
    Gastroenterology; 2017 Apr; 152(5):1042-1054.e1. PubMed ID: 28069350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.
    Sibelli A; Chalder T; Everitt H; Workman P; Windgassen S; Moss-Morris R
    Psychol Med; 2016 Nov; 46(15):3065-3080. PubMed ID: 27605134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A meta-analysis of the prevalence and risk factors of irritable bowel syndrome in Chinese community].
    Zhang L; Duan L; Liu Y; Leng Y; Zhang H; Liu Z; Wang K
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):969-75. PubMed ID: 25623565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis.
    Hu Z; Li M; Yao L; Wang Y; Wang E; Yuan J; Wang F; Yang K; Bian Z; Zhong LLD
    BMC Gastroenterol; 2021 Jan; 21(1):23. PubMed ID: 33413140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.
    Fond G; Loundou A; Hamdani N; Boukouaci W; Dargel A; Oliveira J; Roger M; Tamouza R; Leboyer M; Boyer L
    Eur Arch Psychiatry Clin Neurosci; 2014 Dec; 264(8):651-60. PubMed ID: 24705634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and depression in Indian patients with irritable bowel syndrome: A meta-analysis.
    Ghoshal U; Biswas SN; Dixit VK; Yadav JS
    Indian J Gastroenterol; 2023 Feb; 42(1):32-39. PubMed ID: 36656484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.
    Lee YT; Hu LY; Shen CC; Huang MW; Tsai SJ; Yang AC; Hu CK; Perng CL; Huang YS; Hung JH
    PLoS One; 2015; 10(7):e0133283. PubMed ID: 26222511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan, Iran.
    Modabbernia MJ; Mansour-Ghanaei F; Imani A; Mirsafa-Moghaddam SA; Sedigh-Rahimabadi M; Yousefi-Mashhour M; Joukar F; Atrkar-Roushan Z; Bidel S
    BMC Res Notes; 2012 Feb; 5():112. PubMed ID: 22353390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of anxiety and depression on the risk of irritable bowel syndrome in migraine patients.
    Wu MF; Yang YW; Chen YY
    J Clin Neurosci; 2017 Oct; 44():342-345. PubMed ID: 28694040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.
    Fairbrass KM; Costantino SJ; Gracie DJ; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1053-1062. PubMed ID: 33010814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
    Patel RS; Goyal H; Satodiya R; Tankersley WE
    Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
    [No Abstract]   [Full Text] [Related]  

  • 15. Mood and Anxiety Disorders in Chronic Fatigue Syndrome, Fibromyalgia, and Irritable Bowel Syndrome: Results From the LifeLines Cohort Study.
    Janssens KA; Zijlema WL; Joustra ML; Rosmalen JG
    Psychosom Med; 2015 May; 77(4):449-57. PubMed ID: 25768845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
    Karling P; Danielsson A; Adolfsson R; Norrback KF
    Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of IBS and symptoms of anxiety or depression, among Norwegian twins, is influenced by both heredity and intrauterine growth.
    Bengtson MB; Aamodt G; Vatn MH; Harris JR
    BMC Gastroenterol; 2015 Feb; 15():9. PubMed ID: 25649866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of anxiety and depression among hospitalized patients with irritable bowel syndrome: a nationwide analysis.
    Tarar ZI; Farooq U; Zafar Y; Gandhi M; Raza S; Kamal F; Tarar MF; Ghouri YA
    Ir J Med Sci; 2023 Oct; 192(5):2159-2166. PubMed ID: 36593438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in patients with chronic renal failure.
    Kahvecioglu S; Akdag I; Kiyici M; Gullulu M; Yavuz M; Ersoy A; Dilek K; Yurtkuran M
    J Nephrol; 2005; 18(1):61-6. PubMed ID: 15772924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: anxiety and depression in children and adolescents with inflammatory bowel disease.
    Stapersma L; van den Brink G; Szigethy EM; Escher JC; Utens EMWJ
    Aliment Pharmacol Ther; 2018 Sep; 48(5):496-506. PubMed ID: 29984495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.